PATENT CLAIM ANALYSIS

Application Number: 16013071
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["514", "367000"]

Abstract:
Disclosed herein are methods of treating conditions, which may be associated with elevated levels of plasma cells and/or B-cells, with a therapeutically effective amount of dexpramipexole or pharmaceutical acceptable salt thereof.

Claim (Index 61):
The method of  claim 46 , wherein therapeutically effective amount of R(+) pramipexole or a pharmaceutically acceptable salt thereof is administered via a route of administration selected from the group consisting of orally, by inhalation, intranasally, via intravenous administration, topically, and any combination thereof.

Metadata:
- Claim Count in Document: 107.0
- Percentile: 94.0
- Lexical Diversity: 1.13333
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15461131', '14912015', '15675912', '15889714', '14912058']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8376137643177123
- 35 USC 102 Novelty (BERT): 0.5850190442593208
- Combined Prediction Score: 0.8123542923118732
- Mean Citation Score: 503.378368
- Max Citation Score: 531.966
- Similarity Product: 393.6512621093988

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test